IPAR
Inter Parfums, Inc.
IPAR's fundamentals are mixed: it turned 16% of its revenue into free cash flow, but its operating margin fell 1 points to 18%. At 25x earnings, it's trading below its usual 28x. Analysts expect earnings to hold roughly steady.
IPAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Unavailable |
IPAR's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.
IPAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $119 | -9.1% |
| Current | 25x | $131 | — |
| Fair | 28x | $151 | +15% |
| Forward | 28x | $131 | — |
| Expensive | 37x | $196 | +50% |
Historical ranges are pointers, not guarantees.
IPAR's PE is in its cheap range at 25x. On analysts' estimates for next year's earnings, today's price would be 28x, in its fair range.
IPAR Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect IPAR's profitability to weaken, with its earnings and revenue holding steady.
IPAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.63 | -13% |
| Q3 2026 | $5.31 | +3.3% |
| Q2 2026 | $5.23 | +4.2% |
| Q1 2026 | $5.27 | +1.9% |
| Q4 2025 | $5.24 | +2.3% |
| Q3 2025 | $5.14 | +10% |
| Q2 2025 | $5.02 | +14% |
| Q1 2025 | $5.17 | +19% |
| Q4 2024 | $5.12 | +7.8% |
IPAR's earnings per share have climbed steadily: $5.31 over the past year, up 3.3% from the year before, and higher year over year for eight quarters in a row.
IPAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $429.5M | 0% |
| Q2 2026 | $341M | +2.1% |
| Q1 2026 | $344.9M | +1.8% |
| Q4 2025 | $386.2M | +6.8% |
| Q3 2025 | $429.6M | +1.2% |
| Q2 2025 | $333.9M | -2.4% |
| Q1 2025 | $338.8M | +4.6% |
| Q4 2024 | $361.5M | +10% |
IPAR's revenue grew through 2024 and has held roughly level since: $430M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +2.2 points |
| Q2 2026 | 14% | -3.4 points |
| Q1 2026 | 22% | -0.7 points |
| Q4 2025 | 7.1% | -2.8 points |
| Q3 2025 | 25% | +0.3 points |
| Q2 2025 | 18% | -1.2 points |
| Q1 2025 | 22% | +1.2 points |
| Q4 2024 | 10% | +4.2 points |
IPAR's operating margin was 27% last quarter, up 2.2 points from the same quarter a year ago, near the top of its range since 2019.
IPAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $55.2M | -4.3% |
| Q2 2026 | $44.6M | +$47.9M |
| Q1 2026 | -$1.3M | +$7.5M |
| Q4 2025 | $145M | +6.5% |
| Q3 2025 | $57.6M | -24% |
| Q2 2025 | -$3.3M | -114% |
| Q1 2025 | -$8.8M | +$44.2M |
| Q4 2024 | $136.1M | +71% |
IPAR generated $243M in free cash flow over the past year, up 34% from the year before.
IPAR Net Leverage
IPAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.0 | Neutral |
| Stochastic | 70.2 | Neutral |
IPAR's weekly RSI is 65 (neutral) and its Stochastic is 70 (neutral).
IPAR PE vs Consumer Defensive Sector
| Metric | IPAR | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 19x | 26% above |
| PE % | 26 | 18 | 8 pts above |
IPAR is trading at 25x earnings, a 26% premium to the Consumer Defensive sector's median of 19x.
IPAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $119.7 | 9.2% above |
| 20 week MA | $118.9 | 9.9% above |
| 50 week MA | $103.7 | 26% above |
| 100 week MA | $110.8 | 18% above |
| 200 week MA | $121.1 | 8% above |
IPAR has climbed back above all five of its weekly moving averages, and it's now 8% above its 200-week average.
IPAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.6 | $59.4 | -18% |
| 2021 | $59.4 | $102.1 | +72% |
| 2022 | $102.1 | $98.7 | -3.4% |
| 2023 | $98.7 | $144.0 | +46% |
| 2024 | $144.0 | $131.1 | -9% |
| 2025 | $131.1 | $85.7 | -35% |
| 2026 YTD | $85.7 | $130.8 | +53% |
IPAR is up 53% so far in 2026, after finishing lower in four of the previous six years.